Aarti Drugs Buyback

Aarti Drugs Buyback Details

Spread the love

Aarti Drugs Buyback will open for subscription from 27 April 2021. the company aims for an issue size of ₹60 Crores through this buyback issue.

Aarti Drugs Limited

AD Limited is one of the leading pharma companies in India. The company manufactures over 40 products comprising of bulk actives, key intermediates, and specialty chemicals. Its product portfolio includes anti-biotic, antiprotozoal, anti-inflammatory, anti-fungal, anti-diabetic, cardio-protectant, vitamins, anti-arthritis, sedatives therapeutic groups that help in lifesaving and lifestyle-related diseases. The Company has nine manufacturing locations located at Tarapur (Maharashtra) and two manufacturing locations located at Sarigam (Gujarat), most of them being GMP certified. The company exports its products to over 100 countries worldwide.

Objects of the Issue

  • Improve Return on Equity.
  • Service the equity more efficiently.
  • Improve earnings per share and thus increase the shareholder’s value in the long-term.
  • Return surplus cash to the shareholders.

Aarti Drugs Buyback Issue Timetable

Offer Opens On27 April 2021
Offer Closes On10 May 2021
Record Date01 April2021
Last Date for receipt of Tender Forms12 May 2021
Finalisation of Buyback Acceptance19 May 2021
Last Date for settlment of bids20 May 2021
Last Date for Extinguishment of Shares27 May 2021

Aarti Drugs Buyback Details

Security NameAarti Drugs Limited
Issue TypeTender Offer
Issue Size (Shares)0.06 Crores
Issue Size (Amount)₹60.00 Crores
Buyback Price₹1000 per share
Face Value₹10 per share
Listing AtBSE, NSE

Buyback Ratio

CategoryEntitlement Ratio of Buyback
Reserved Category for Small Shareholders8 Equity Shares out of every 569 paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders5 Equity Shares out of every 851 paid-up Equity Shares held on the Record Date.

Company Financials

ParticularsFor the year/period ended (Rs. in Millions)
Total Income18,075.7115,671.1712,636.18
Profit After Tax1,413.99897.52823.07
Net Worth6,467.455,373.094,502.79

Stock Market Data (for preceding 3 months)


MonthHigh PriceLow PriceAverage Price


MonthHigh PriceLow PriceAverage Price
MonthHigh PriceLow PriceAverage Price

Aarti Drugs Buyback Registrar

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083

Phone: +91-22-4918 6270
Email: aartidrugs.buyback2021@linkintime.co.in

Company Contact Information

Aarti Drugs Limited
Plot No. – N-198,
M.I.D.C., Village – Pamtermbhi
Taluka & Dist. Palghar – 401 506

Phone: +91 22 2404 8199
Email: investorrelations@aartidrugs.com

Final Thoughts

A buyback occurs when the issuing company pays shareholders the market value per share and re-absorbs that portion of its ownership that was previously distributed among public and private investors. subscribing for a buyback issue is purely a personal choice. make a detailed study before you make a decision on buyback issue subscription.

Happy Investing

Spread the love

Leave a Comment

Your email address will not be published. Required fields are marked *